Patient self-reported experience and satisfaction with golimumab and etanercept treatments for rheumatic diseases: A cohort study.

3 D) were lower in the golimumab group than in the etanercept group; meanwhile, the sting level showed a decreasing trend (without statistical significance) in the golimumab group than in the etanercept group ( P = .061, Fig. 3 E).

also in 47,180 other papers